secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORTHOPEDIATRICS CORP (KIDS)
CIK:        0001425450
Form:       8-K
Filed at:   2025-05-07T23:59:59+00:00
Accession:  0001425450-25-000047
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OrthoPediatrics Q1 revenue $52.4M (+17% YoY); raises FY2025 guidance to $236-242M
--------------------------------------------------------------------------------

- Total Q1 revenue $52.4M (+17% YoY); U.S. revenue $40.9M (+19%), international $11.5M (+11%).
- Net loss $10.7M ($0.46 per share) vs. $7.8M ($0.34) in Q1 2024; adjusted EBITDA loss improved to ($0.4M) from ($1.1M).
- FY2025 revenue guidance raised to $236M-$242M (15-18% growth); adjusted EBITDA guidance reiterated at $15-17M.
- Scoliosis revenue grew 34% to $13.7M; launched VerteGlide system for Early Onset Scoliosis.
- Cash, equivalents and restricted cash $60.8M at quarter end vs. $70.8M at Dec 31, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1425450/000142545025000047/0001425450-25-000047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1425450/000142545025000047/kids-20250507.htm
  HTML page:      https://secwatch.observer/filing/0001425450-25-000047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer